Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 10 | 2022 | 643 | 3.300 |
Why?
|
| Voltage-Dependent Anion Channels | 8 | 2022 | 40 | 2.420 |
Why?
|
| Membrane Potential, Mitochondrial | 7 | 2020 | 93 | 1.610 |
Why?
|
| Neoplasms | 8 | 2020 | 1667 | 1.590 |
Why?
|
| NAD | 2 | 2022 | 73 | 1.550 |
Why?
|
| Liver Neoplasms | 4 | 2022 | 334 | 1.510 |
Why?
|
| Tubulin | 4 | 2017 | 60 | 1.480 |
Why?
|
| Energy Metabolism | 5 | 2022 | 222 | 1.350 |
Why?
|
| Adenosine Triphosphate | 5 | 2022 | 314 | 1.300 |
Why?
|
| Mitochondria, Liver | 4 | 2019 | 148 | 1.280 |
Why?
|
| Piperazines | 3 | 2017 | 206 | 1.060 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2019 | 163 | 1.000 |
Why?
|
| Hepatocytes | 6 | 2017 | 205 | 0.980 |
Why?
|
| Oxygen Consumption | 3 | 2022 | 258 | 0.980 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 307 | 0.830 |
Why?
|
| Adenosine Diphosphate | 3 | 2016 | 66 | 0.780 |
Why?
|
| Mitochondrial Membranes | 1 | 2020 | 45 | 0.730 |
Why?
|
| Cell Cycle | 1 | 2020 | 312 | 0.670 |
Why?
|
| Simvastatin | 1 | 2019 | 34 | 0.660 |
Why?
|
| Glycolysis | 3 | 2016 | 79 | 0.640 |
Why?
|
| Lovastatin | 1 | 2019 | 78 | 0.640 |
Why?
|
| Hep G2 Cells | 5 | 2020 | 68 | 0.630 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1174 | 0.620 |
Why?
|
| Lactates | 1 | 2017 | 29 | 0.600 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 212 | 0.570 |
Why?
|
| Adenine Nucleotide Translocator 2 | 1 | 2016 | 3 | 0.560 |
Why?
|
| Adenine Nucleotide Translocator 3 | 1 | 2016 | 3 | 0.560 |
Why?
|
| Glycerophospholipids | 3 | 2014 | 20 | 0.520 |
Why?
|
| Fatty Acids, Unsaturated | 9 | 2007 | 84 | 0.500 |
Why?
|
| E2F2 Transcription Factor | 1 | 2014 | 29 | 0.490 |
Why?
|
| Liver Regeneration | 1 | 2014 | 38 | 0.480 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1070 | 0.470 |
Why?
|
| Fatty Acids | 6 | 2014 | 222 | 0.450 |
Why?
|
| Homeostasis | 1 | 2014 | 291 | 0.440 |
Why?
|
| Animals | 24 | 2018 | 20881 | 0.420 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 113 | 0.420 |
Why?
|
| Mixed Function Oxygenases | 2 | 2007 | 35 | 0.370 |
Why?
|
| Rats | 13 | 2017 | 5300 | 0.360 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1173 | 0.360 |
Why?
|
| Lipids | 7 | 2007 | 298 | 0.340 |
Why?
|
| Liver | 2 | 2014 | 1118 | 0.340 |
Why?
|
| Galactolipids | 2 | 2007 | 4 | 0.320 |
Why?
|
| Fatty Acids, Omega-3 | 5 | 2003 | 41 | 0.300 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 1851 | 0.300 |
Why?
|
| Sciatic Nerve | 1 | 2007 | 26 | 0.300 |
Why?
|
| Schwann Cells | 1 | 2007 | 33 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2016 | 2083 | 0.290 |
Why?
|
| Myelin Sheath | 1 | 2007 | 115 | 0.290 |
Why?
|
| Chylomicrons | 2 | 2003 | 6 | 0.280 |
Why?
|
| Molecular Structure | 2 | 2017 | 397 | 0.280 |
Why?
|
| Ethanol | 1 | 2011 | 893 | 0.250 |
Why?
|
| Fish Oils | 3 | 2003 | 21 | 0.250 |
Why?
|
| Nocodazole | 2 | 2017 | 11 | 0.250 |
Why?
|
| Humans | 15 | 2022 | 68618 | 0.250 |
Why?
|
| Lipoproteins, HDL | 2 | 2002 | 113 | 0.240 |
Why?
|
| Corn Oil | 2 | 2003 | 8 | 0.240 |
Why?
|
| Triglycerides | 4 | 2014 | 184 | 0.230 |
Why?
|
| Dogs | 2 | 2002 | 490 | 0.220 |
Why?
|
| Phosphatidylcholines | 3 | 2014 | 38 | 0.220 |
Why?
|
| Testis | 4 | 2007 | 37 | 0.220 |
Why?
|
| Sphingomyelins | 4 | 2007 | 106 | 0.210 |
Why?
|
| Mammals | 1 | 2002 | 47 | 0.210 |
Why?
|
| eIF-2 Kinase | 1 | 2022 | 49 | 0.200 |
Why?
|
| Cell Respiration | 1 | 2022 | 47 | 0.200 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 58 | 0.200 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 78 | 0.200 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2011 | 93 | 0.190 |
Why?
|
| Voltage-Dependent Anion Channel 2 | 1 | 2020 | 9 | 0.180 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2020 | 10 | 0.180 |
Why?
|
| Isoflavones | 1 | 2020 | 31 | 0.180 |
Why?
|
| Lipoproteins | 1 | 2001 | 161 | 0.180 |
Why?
|
| Cholesterol Esters | 4 | 2007 | 26 | 0.170 |
Why?
|
| Reactive Oxygen Species | 2 | 2020 | 499 | 0.160 |
Why?
|
| Cells, Cultured | 7 | 2014 | 2673 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 111 | 0.150 |
Why?
|
| Molecular Imaging | 1 | 2017 | 45 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 48 | 0.150 |
Why?
|
| Protein Multimerization | 1 | 2017 | 71 | 0.140 |
Why?
|
| Workflow | 1 | 2017 | 100 | 0.140 |
Why?
|
| Cell Death | 1 | 2017 | 329 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2017 | 178 | 0.140 |
Why?
|
| Pyridines | 1 | 2017 | 261 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1745 | 0.120 |
Why?
|
| Phosphatidylethanolamines | 1 | 2014 | 20 | 0.120 |
Why?
|
| Autophagy | 2 | 2022 | 208 | 0.120 |
Why?
|
| Colchicine | 2 | 2011 | 48 | 0.120 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2014 | 39 | 0.120 |
Why?
|
| ADAM Proteins | 1 | 2014 | 53 | 0.120 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2014 | 46 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 209 | 0.120 |
Why?
|
| Male | 13 | 2016 | 37321 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2014 | 1692 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 175 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 659 | 0.110 |
Why?
|
| NADP | 1 | 2013 | 39 | 0.110 |
Why?
|
| Lipid Bilayers | 1 | 2013 | 24 | 0.110 |
Why?
|
| Ceramides | 2 | 2007 | 578 | 0.110 |
Why?
|
| Mice | 6 | 2014 | 8474 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 196 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 498 | 0.100 |
Why?
|
| Phospholipids | 4 | 2007 | 108 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 65 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2014 | 431 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 567 | 0.100 |
Why?
|
| Cyclic CMP | 1 | 2010 | 2 | 0.090 |
Why?
|
| Rotenone | 1 | 2010 | 10 | 0.090 |
Why?
|
| Proteins | 1 | 2014 | 474 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 57 | 0.090 |
Why?
|
| Rhodamines | 1 | 2010 | 27 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 64 | 0.090 |
Why?
|
| Membrane Potentials | 1 | 2010 | 200 | 0.090 |
Why?
|
| Microtubules | 1 | 2010 | 104 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2010 | 140 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2010 | 223 | 0.090 |
Why?
|
| Fatty Acids, Omega-6 | 4 | 2003 | 12 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2010 | 525 | 0.080 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 104 | 0.070 |
Why?
|
| Biological Transport | 2 | 2009 | 210 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2009 | 1664 | 0.070 |
Why?
|
| Models, Biological | 1 | 2011 | 981 | 0.070 |
Why?
|
| Cryptorchidism | 1 | 2007 | 7 | 0.070 |
Why?
|
| Spermatozoa | 1 | 2007 | 75 | 0.070 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2007 | 82 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2007 | 231 | 0.070 |
Why?
|
| Prostaglandins | 1 | 2004 | 65 | 0.060 |
Why?
|
| Receptors, Prostaglandin | 1 | 2004 | 74 | 0.060 |
Why?
|
| Lipid Metabolism | 2 | 2007 | 186 | 0.060 |
Why?
|
| Apoptosis | 2 | 2022 | 1641 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2004 | 330 | 0.050 |
Why?
|
| Armadillos | 1 | 2002 | 1 | 0.050 |
Why?
|
| Lysophosphatidylcholines | 1 | 2002 | 11 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 682 | 0.050 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2001 | 8 | 0.050 |
Why?
|
| Rats, Wistar | 3 | 2007 | 371 | 0.050 |
Why?
|
| Cats | 1 | 2002 | 292 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 99 | 0.050 |
Why?
|
| Clofibrate | 1 | 2001 | 2 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2001 | 103 | 0.050 |
Why?
|
| Hypolipidemic Agents | 1 | 2001 | 82 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2020 | 111 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 597 | 0.040 |
Why?
|
| Germ Cells | 2 | 2007 | 17 | 0.040 |
Why?
|
| Brain | 1 | 2006 | 2176 | 0.030 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2014 | 17 | 0.030 |
Why?
|
| ADAM17 Protein | 1 | 2014 | 28 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2014 | 30 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 79 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 194 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2014 | 239 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2011 | 37 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 73 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 947 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2011 | 141 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2009 | 33 | 0.020 |
Why?
|
| Phagosomes | 1 | 2009 | 19 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2009 | 41 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2009 | 75 | 0.020 |
Why?
|
| Adenine | 1 | 2009 | 46 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2009 | 51 | 0.020 |
Why?
|
| Permeability | 1 | 2009 | 131 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 546 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 84 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2009 | 121 | 0.020 |
Why?
|
| Female | 3 | 2014 | 38074 | 0.020 |
Why?
|
| Lysosomes | 1 | 2009 | 136 | 0.020 |
Why?
|
| Amines | 1 | 2009 | 98 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 1027 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1200 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 215 | 0.020 |
Why?
|
| Sertoli Cells | 1 | 2007 | 4 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2007 | 7 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 2007 | 52 | 0.020 |
Why?
|
| Cations | 1 | 2007 | 51 | 0.020 |
Why?
|
| Detergents | 1 | 2007 | 34 | 0.020 |
Why?
|
| Fertility | 1 | 2007 | 60 | 0.020 |
Why?
|
| X-Rays | 1 | 2007 | 56 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2006 | 41 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2550 | 0.020 |
Why?
|
| Species Specificity | 1 | 2007 | 303 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 302 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 341 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 396 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2009 | 753 | 0.020 |
Why?
|
| Base Sequence | 1 | 2006 | 1015 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 1083 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1447 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1293 | 0.010 |
Why?
|
| Diglycerides | 1 | 2003 | 49 | 0.010 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2001 | 7 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 2791 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 532 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 4655 | 0.010 |
Why?
|
| Inflammation | 1 | 2004 | 1030 | 0.010 |
Why?
|